SOPROBEC

This brand name is authorized in Spain, Malta, Poland, Romania, United Kingdom

Active ingredients

The drug SOPROBEC contains one active pharmaceutical ingredient (API):

1 Beclometasone UNII 5B307S63B2 - BECLOMETHASONE DIPROPIONATE

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity. Read about Beclometasone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SOPROBEC Pressurised inhalation solution	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03BA01	Beclometasone	R Respiratory system → R03 Drugs for obstructive airway diseases → R03B Other drugs for obstructive airway diseases, inhalants → R03BA Glucocorticoids
Discover more medicines within R03BA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 84741, 84742, 84743, 84744
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 366033, 366035, 366037, 366039
Country: MT	Medicines Authority	Identifier(s): AA565/62701
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100424607, 100424613, 100424620, 100424636
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67207001, W67208001, W67209001, W67210001